Prota cracks $20m raising for its allergy treatment
MELBOURNE: Australian biotech Prota Therapeutics is chasing $20 million to prepare Phase 3 testing for
MELBOURNE: Australian biotech Prota Therapeutics is chasing $20 million to prepare Phase 3 testing for